Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $65.6 million.

  • Burning Rock Biotech's Cash & Current Investments fell 761.13% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.6 million, marking a year-over-year decrease of 761.13%. This contributed to the annual value of $71.5 million for FY2024, which is 1745.97% down from last year.
  • As of Q3 2025, Burning Rock Biotech's Cash & Current Investments stood at $65.6 million, which was down 761.13% from $63.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Cash & Current Investments high stood at $322.5 million for Q1 2021, and its period low was $63.5 million during Q2 2025.
  • Its 5-year average for Cash & Current Investments is $137.1 million, with a median of $101.1 million in 2023.
  • As far as peak fluctuations go, Burning Rock Biotech's Cash & Current Investments soared by 1208714.14% in 2021, and later tumbled by 4409.27% in 2022.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Cash & Current Investments stood at $195.9 million in 2021, then plummeted by 31.5% to $134.2 million in 2022, then tumbled by 35.41% to $86.7 million in 2023, then dropped by 17.44% to $71.5 million in 2024, then decreased by 8.3% to $65.6 million in 2025.
  • Its Cash & Current Investments stands at $65.6 million for Q3 2025, versus $63.5 million for Q2 2025 and $68.5 million for Q1 2025.